These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 31689713)

  • 21. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
    Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
    Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased brain age in adults with Prader-Willi syndrome.
    Azor AM; Cole JH; Holland AJ; Dumba M; Patel MC; Sadlon A; Goldstone AP; Manning KE
    Neuroimage Clin; 2019; 21():101664. PubMed ID: 30658944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial.
    Kuppens RJ; Mahabier EF; Bakker NE; Siemensma EP; Donze SH; Hokken-Koelega AC
    Orphanet J Rare Dis; 2016 Nov; 11(1):153. PubMed ID: 27852283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome.
    Priano L; Grugni G; Miscio G; Guastamacchia G; Toffolet L; Sartorio A; Mauro A
    Sleep Med; 2006 Dec; 7(8):627-33. PubMed ID: 17023209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
    Festen DA; Visser TJ; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Moro D; Bettio D; De Medici C; Morabito F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):769-75. PubMed ID: 9713567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
    Verrillo E; Bruni O; Franco P; Ferri R; Thiriez G; Pavone M; Petrone A; Paglietti MG; Crinò A; Cutrera R
    Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome.
    Grugni G; Crinò A; Pagani S; Meazza C; Buzi F; De Toni T; Gargantini L; Pilotta A; Pozzan GB; Radetti G; Ragusa L; Salvatoni A; Sartorio A; Bozzola M;
    J Pediatr Endocrinol Metab; 2011; 24(7-8):477-81. PubMed ID: 21932585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
    Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
    Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
    Grugni G; Marzullo P
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.
    Jørgensen AP; Ueland T; Sode-Carlsen R; Schreiner T; Rabben KF; Farholt S; Høybye C; Christiansen JS; Bollerslev J
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E753-60. PubMed ID: 23436915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GHRH plus arginine and arginine administration evokes the same ratio of GH isoforms levels in young patients with Prader-Willi syndrome.
    Rigamonti AE; Crinò A; Bocchini S; Convertino A; Bidlingmaier M; Haenelt M; Tamini S; Cella SG; Grugni G; Sartorio A
    Growth Horm IGF Res; 2018 Apr; 39():13-18. PubMed ID: 29217318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of gait analysis in the rehabilitation of adult patients with "Prader-Willi" Syndrome: a cross-sectional comparative study ("Prader-Willi" Syndrome vs matched obese patients and healthy subjects).
    Vismara L; Romei M; Galli M; Montesano A; Baccalaro G; Crivellini M; Grugni G
    J Neuroeng Rehabil; 2007 May; 4():14. PubMed ID: 17493259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
    Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ageing in people with Prader-Willi syndrome: mortality in the UK population cohort and morbidity in an older sample of adults.
    Whittington JE; Holland AJ; Webb T
    Psychol Med; 2015 Feb; 45(3):615-21. PubMed ID: 25088280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment.
    Angulo MA; Castro-Magana M; Lamerson M; Arguello R; Accacha S; Khan A
    Am J Med Genet A; 2007 Jul; 143A(13):1456-61. PubMed ID: 17567883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
    J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.